SUNPHARMA.NS Cash Flow
Sun Pharmaceutical Industries Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-24 01:42
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹4,959.33 Cr. | ₹12,134.98 Cr. | ₹14,072.09 Cr. | ₹12,419.18 Cr. | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-7,943.68 Cr. | ₹-690.20 Cr. | ₹-5,306.16 Cr. | ₹-11,344.05 Cr. | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹2,376.07 Cr. | ₹-6,710.16 Cr. | ₹-7,905.82 Cr. | ₹-2,512.55 Cr. | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹723.76 Cr. | ₹-72.70 Cr. | ₹123.01 Cr. | ₹939.16 Cr. | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹115.48 Cr. | ₹4,661.92 Cr. | ₹983.12 Cr. | ₹-498.26 Cr. | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹4,508.25 Cr. | ₹4,623.73 Cr. | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from SUNPHARMA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).